A single elective stent placed in a stable patient with normal heart function is a modest underwriting factor, and by itself it rarely turns a policy into a valuable one; a stent placed during a heart attack, in a patient with reduced ejection fraction or multi-vessel disease, is a different file entirely. The distinction is in the cardiac catheterization report and the echocardiogram, not in the word stent.
Households usually arrive at this question because a premium notice grew, or because somebody suggested that a heart procedure makes an old policy sellable. That suggestion is half true and the half that is false costs people three months of records gathering for an offer they decline.
Below is what underwriters actually read, and then the realistic options ranked from best to worst for a typical household with an in-force policy and a recent stent. Confirm all medical details with the treating cardiologist and all policy figures with the carrier, in writing.
In This Article
- What the File Actually Says: The Six Facts Underwriters Weigh
- Option 1: Ask the Carrier Four Free Questions First
- Option 2: Keep Paying and Do Nothing Different
- Option 3: Use a Rider That Is Already in the Contract
- Option 4: Surrender for Cash Value
- Option 5: A Life Settlement, With the Stent Priced Honestly
- Option 6, Last: Let It Lapse, and When Selling Is Simply Wrong
- Frequently Asked Questions
What the File Actually Says: The Six Facts Underwriters Weigh
Life expectancy providers, firms such as ITM TwentyFirst, Fasano Associates or Longevity Services, build a mortality multiplier from records rather than from a procedure name. Six items drive the assessment after a percutaneous coronary intervention.
- Elective or emergent. A stent placed electively for stable angina reads very differently from one placed during an acute myocardial infarction.
- Ejection fraction. The single most influential number. Preserved function after a stent is largely reassuring; reduced function is not.
- Number of vessels involved, and whether disease remains untreated in other vessels.
- Time since the procedure. The first year carries more risk than the fourth, and stability over time improves the picture.
- Risk factor control: blood pressure, lipids, diabetes status and smoking. Documented control matters as much as the procedure itself.
- Comorbidity, particularly chronic kidney disease, diabetes with complications, prior stroke, or heart failure. These are what usually move a file, with the stent as the label on the folder.
Order the catheterization report, the most recent echocardiogram with ejection fraction, the discharge summary, and two to five years of cardiology and primary care notes. Ordering once and copying is faster than repeating requests. See how life expectancy underwriting works.
Option 1: Ask the Carrier Four Free Questions First
Ranked first because it costs nothing, takes one phone call plus a written request, and resolves most households’ actual problem.
What is the minimum premium required to keep this contract in force for the next twelve months, and to age 100 at guaranteed assumptions? On universal life the number being paid is frequently not the number required.
What reduced paid-up face amount is available with no further premiums at all? For a household whose problem is the premium rather than the coverage, this often ends the inquiry.
What would reducing the face amount do to the premium? Cutting a $500,000 policy to $200,000 can bring the cost into range while keeping meaningful coverage.
Which riders does the contract already contain? Accelerated death benefit, chronic illness, long-term care and waiver of premium riders are common in permanent policies issued in the past thirty years and are routinely forgotten by owners.
Who it suits: every household, before doing anything else. Request an in-force illustration in writing along with the answers.
Option 2: Keep Paying and Do Nothing Different
An unglamorous option that is correct more often than any other on this page.
If the premium is affordable, if someone would genuinely be worse off without the death benefit, and if the stent was elective with preserved heart function, the honest advice is that nothing about the procedure requires a decision. A stent is a treatment, not a prognosis, and many people live decades after one.
Two maintenance items while you do nothing. Confirm the beneficiary designation is current, since divorces, deaths and remarriages leave stale designations everywhere. And if the policy is universal life, request an in-force illustration every two or three years, because rising cost of insurance charges can quietly consume account value and lapse a policy the owner believed was funded.
Who it suits: households with an affordable premium and a real need for the coverage. That is most households after a first stent.
| Rank | Option | Cost or speed | Who it suits |
|---|---|---|---|
| 1 | Four free questions to the carrier | One call plus a written request | Every household, first |
| 2 | Keep paying, update the beneficiary | No change | Affordable premium, coverage still needed |
| 3 | Rider already in the contract, or a policy loan | 2 to 8 weeks | Immediate cash need, permanent policy |
| 4 | Surrender for cash value | 2 to 6 weeks | Meaningful cash value, no continuing need |
| 5 | Life settlement | 60 to 120 days | Large policy, impairment beyond the stent |
| 6 | Lapse | Immediate, returns nothing | Unwanted policy with no value and no market |
Option 3: Use a Rider That Is Already in the Contract
If the pressure is a cash need rather than a premium problem, look inside the policy before looking outside it.
An accelerated death benefit rider advances part of the face amount on a qualifying physician certification, typically for terminal illness, and some contracts include chronic illness riders that trigger on documented inability to perform activities of daily living. These pay in weeks, cost far less than selling the policy, and reduce the remaining death benefit by the amount advanced plus any charge.
Ask the carrier three things in writing: the exact trigger, the maximum advance available, and the effect on the remaining death benefit. Note that a stable patient after an elective stent will usually not meet a terminal illness trigger, so this option is realistic for households where the cardiac disease is one part of a larger picture.
A policy loan against cash value is the other internal option. It is generally not taxable while the policy remains in force, but unpaid interest compounds and can lapse the contract, which produces a tax bill at the worst moment. Ask for the loan rate and an illustration showing the loan carried forward.
Who it suits: households with permanent coverage and an immediate cash need.
Option 4: Surrender for Cash Value
Fourth because it is fast, certain, and usually leaves money on the table when a policy has market value.
Ask the carrier for the current net cash surrender value in writing, after surrender charges and any outstanding loan. That figure is the floor beneath every other option, and no offer should ever be accepted below it.
The tax treatment is straightforward: gain above your investment in the contract is ordinary income in the year of surrender, and the carrier will issue a Form 1099-R. Ask your CPA what that does to your bracket, to the taxable share of Social Security, and to Medicare income-related premium adjustments two years later.
Surrender makes sense when the cash value is substantial relative to the face amount, when a settlement market does not exist for the policy, and when the money is needed now rather than in four months. Compare it against reduced paid-up before deciding, since reduced paid-up keeps coverage without further premiums. See what cash surrender value actually is.
Who it suits: owners of older whole life policies with meaningful cash value and no continuing need for coverage.
Option 5: A Life Settlement, With the Stent Priced Honestly
Fifth for a specific profile and not for the typical post-stent household.
Buyers are generally interested where the life expectancy estimate falls inside a range of roughly two to fifteen years, with better pricing at the shorter end. A 74-year-old with one elective stent, an ejection fraction in the normal range, controlled lipids and no diabetes will frequently produce an estimate at or beyond the long end, meaning no offer or a low one. Add reduced ejection fraction, prior myocardial infarction, chronic kidney disease or insulin-dependent diabetes and the picture changes materially.
If you pursue it, work with a licensed broker who represents you rather than a provider buying for its own account, ask how many providers the policy will be shopped to, ask that every offer be disclosed in writing, and ask for the gross offer and your net as separate numbers. The federal Government Accountability Office study GAO-10-775 documented payouts well above cash surrender value and far below face amount across a wide range, which is the honest way to describe the outcome distribution.
Who it suits: a substantial permanent policy, generally $100,000 of face or more, with an unaffordable premium, a documented impairment beyond the stent alone, and nobody depending on the death benefit. Compare with how diabetes control is underwritten and how sleep apnea is treated, both of which commonly appear in the same file.
Option 6, Last: Let It Lapse, and When Selling Is Simply Wrong
Lapsing is ranked last because it returns nothing, and because it is almost always avoidable through options one and two. If a policy is genuinely unwanted and has no cash value and no market, allowing it to lapse is a legitimate end, but check the first four options before concluding that.
When selling is the wrong answer, stated plainly. Small face amounts, generally under about $100,000, where transaction costs consume too large a share and the net lands near the surrender value. A final expense or burial policy assigned to a funeral home under a pre-need contract, which typically sits inside the burial exclusion benefit programs recognize. A household where a surviving spouse depends on the death benefit, which the stent does not change. A healthy insured, where the market will price accordingly and the process wastes months. And any situation where Medicaid may be needed soon, since a lump sum is a countable resource in the month it arrives.
One more caution specific to this page: do not let a policy lapse while exploring a sale. A lapsed policy has no market value, and reinstatement requires evidence of insurability plus back premiums with interest, which after a cardiac event may be unavailable.
Pine Lake Legacy does not purchase policies and is not licensed in every state. A free policy review is education about your own contract, and it is not medical or tax advice; those belong with your cardiologist and your CPA. Our page on what a policy is worth explains the valuation inputs, and what a broker does covers who represents whom.
Frequently Asked Questions
Does having a stent make my life insurance policy worth selling?
Usually not on its own. A single elective stent in a stable patient with preserved ejection fraction is a modest mortality factor, and life expectancy estimates often come back long enough that buyers pass or bid low. What changes the picture is a stent placed during a heart attack, reduced ejection fraction, multi-vessel disease, or significant comorbidity such as kidney disease.
What medical records will underwriters want?
The cardiac catheterization report showing the vessels treated, the most recent echocardiogram with ejection fraction, the hospital discharge summary from the procedure, and two to five years of cardiology and primary care notes including lipid and kidney function results and the medication list. Order these once from the treating practices and keep the originals to provide copies.
Should I tell my insurance company about the stent?
An in-force policy past its contestability period generally does not require you to report new medical events, and your premium on a fixed contract does not change because of them. If you are applying for new coverage, answer every question completely and truthfully, since a material misrepresentation can support a contest of a claim within the contestable period.
Is it better to surrender or to sell?
Get the net cash surrender value in writing from the carrier first, because that is the floor. A settlement is worth pursuing only if an offer meaningfully exceeds it after fees and after tax. For many post-stent households with stable heart function, the market does not produce such an offer, and reduced paid-up coverage beats both options.
How long does it take to find out what the market would pay?
Expect 60 to 120 days from application to funding, with most of the time spent on medical records retrieval and life expectancy underwriting. Records requests to physician practices commonly take two to four weeks each. Keep paying premiums throughout, since a lapse ends the process and eliminates any value the policy had.
My universal life premium keeps rising after the stent. Are those connected?
No. Cost of insurance charges on universal life rise with attained age under the contract’s terms, and some carriers have implemented cost of insurance increases across blocks of business. Neither is triggered by your medical history on an in-force policy. Request an in-force illustration to see where the account value is heading and what minimum premium would sustain it.
Find out what your policy is worth — free, confidential, no obligation.
A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.
Related Reading
- What Is Life Expectancy Underwriting
- Sleep Apnea And Underwriting
- Diabetes Control And Underwriting
- What Is An In Force Illustration
- What Is Cash Surrender Value
- What Is A Life Settlement Broker
- How Much Is My Policy Worth
- What Is A Life Settlement
Pine Lake Legacy does not purchase life insurance policies and does not provide legal, tax, or investment advice. Information provided is for educational purposes only. Eligibility for any option, including life settlements, is not guaranteed and depends on individual circumstances, policy terms, underwriting, and market conditions. Consult independent legal, tax, or financial professionals before making decisions regarding a life insurance policy.